Market Currents
AbbVie - Abbott Labs (ABT -0.1%) proprietary pharmaceuticals business once the company splits in...
-
Monday, November 5, 2012, 2:34 PM ETAbbVie - Abbott Labs (ABT -0.1%) proprietary pharmaceuticals business once the company splits in two - is selling $14.7B in one of the biggest-ever dollar-denominated debt issues in the US high-grade market. The company is offering three-year fixed-rate, three-year floating-rate, five-year, six-year, 10-year and 30-year notes in a six-part deal that is expected to price later today.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
